BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9927054)

  • 1. The use of Zn-desferrioxamine for radioprotection in mice, tissue culture, and isolated DNA.
    Samuni Y; Coffin D; DeLuca AM; DeGraff WG; Venson DJ; Ambudkar I; Chevion M; Mitchell JB
    Cancer Res; 1999 Jan; 59(2):405-9. PubMed ID: 9927054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desferrioxamine and zinc-desferrioxamine reduce lens oxidative damage.
    Schaal S; Beiran I; Rozner H; Rubinstein I; Chevion M; Miller B; Dovrat A
    Exp Eye Res; 2007 Mar; 84(3):561-8. PubMed ID: 17239855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel protection strategy against X-ray-induced damage to salivary glands.
    Nagler R; Marmary Y; Golan E; Chevion M
    Radiat Res; 1998 Mar; 149(3):271-6. PubMed ID: 9496890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc-desferrioxamine reduces damage to lenses exposed to hyperbaric oxygen and has an ameliorative effect on catalase and Na, K-ATPase activities.
    Schaal S; Beiran I; Bormusov E; Chevion M; Dovrat A
    Exp Eye Res; 2007 Mar; 84(3):455-63. PubMed ID: 17174302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc-desferrioxamine attenuates retinal degeneration in the rd10 mouse model of retinitis pigmentosa.
    Obolensky A; Berenshtein E; Lederman M; Bulvik B; Alper-Pinus R; Yaul R; Deleon E; Chowers I; Chevion M; Banin E
    Free Radic Biol Med; 2011 Oct; 51(8):1482-91. PubMed ID: 21824515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term systemic effects of head and neck irradiation.
    Nagler RM; Barak V; Nagler A
    Anticancer Res; 2000; 20(3A):1865-70. PubMed ID: 10928120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox metal chelation ameliorates radiation-induced bone marrow toxicity in a mouse model.
    Nagler RM; Eichen Y; Nagler A
    Radiat Res; 2001 Aug; 156(2):205-9. PubMed ID: 11448242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of gamma radiation induced response of peritoneal macrophages and splenocytes by Hippophae rhamnoides (RH-3) in mice.
    Prakash H; Bala M; Ali A; Goel HC
    J Pharm Pharmacol; 2005 Aug; 57(8):1065-72. PubMed ID: 16102264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5,7-Dihydroxychromone-2-carboxylic acid and it's transition-metal (Mn and Zn) chelates as non-thiol radioprotective agents.
    Hosseinimehr SJ; Emami S; Taghdisi SM; Akhlaghpoor S
    Eur J Med Chem; 2008 Mar; 43(3):557-61. PubMed ID: 17602799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage.
    Kurz T; Leake A; Von Zglinicki T; Brunk UT
    Biochem J; 2004 Mar; 378(Pt 3):1039-45. PubMed ID: 14670081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA protective properties of vanillin against gamma-radiation under different conditions: possible mechanisms.
    Maurya DK; Adhikari S; Nair CK; Devasagayam TP
    Mutat Res; 2007 Dec; 634(1-2):69-80. PubMed ID: 17644025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids.
    Morad Y; Banin E; Averbukh E; Berenshtein E; Obolensky A; Chevion M
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1640-6. PubMed ID: 15851563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of nitroxides in radiation oncology.
    Hahn SM; Krishna CM; Samuni A; DeGraff W; Cuscela DO; Johnstone P; Mitchell JB
    Cancer Res; 1994 Apr; 54(7 Suppl):2006s-2010s. PubMed ID: 8137329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo radioprotection by 5-aminosalicylic acid.
    Mantena SK; Unnikrishnan MK; Joshi R; Radha V; Devi PU; Mukherjee T
    Mutat Res; 2008 Jan; 650(1):63-79. PubMed ID: 18155638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tempol, a stable free radical, is a novel murine radiation protector.
    Hahn SM; Tochner Z; Krishna CM; Glass J; Wilson L; Samuni A; Sprague M; Venzon D; Glatstein E; Mitchell JB
    Cancer Res; 1992 Apr; 52(7):1750-3. PubMed ID: 1551104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against radiation oxidative damage in mice by Triphala.
    Sandhya T; Lathika KM; Pandey BN; Bhilwade HN; Chaubey RC; Priyadarsini KI; Mishra KP
    Mutat Res; 2006 Oct; 609(1):17-25. PubMed ID: 16860592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioprotective role of clinical drug diclofenac sodium.
    Alok A; Adhikari JS; Chaudhury NK
    Mutat Res; 2013 Aug; 755(2):156-62. PubMed ID: 23827778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioprotective effects of various cytokines in peripheral blood mononuclear cells and C3H mice.
    Kim JY; Oh SJ; Park HK; Yoon JS; Kim ES; Kim ES; Kim CS; Lee YY; Kim BK
    Oncol Rep; 2005 Jun; 13(6):1177-83. PubMed ID: 15870940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free radical scavenging and radioprotective activity of dehydrozingerone against whole body gamma irradiation in Swiss albino mice.
    Parihar VK; Dhawan J; Kumar S; Manjula SN; Subramanian G; Unnikrishnan MK; Rao CM
    Chem Biol Interact; 2007 Oct; 170(1):49-58. PubMed ID: 17765885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.